Finally, using Kaplan-Meier survival curves, we analyzed the clinical significance of ADGRF5 expression signature in patients with CRC and showed that CRC patients with increased expression of ADGRF5 in the colon had an inferior probability of OS and DFS compared to CRC patients with reduced ADGRF5 expression in the colon. Here, ADGRF5 is linked to colorectal carcinoma.